As a result of the successful conclusion of the regulatory...

As a result of the successful conclusion of the regulatory process and customary closing conditions, Nestlé today completed its acquisition of L’Oréal’s 50% stake in Galderma, as originally announced on 11 February 2014.
Galderma, with approximately 5,000 employees and a presence in 80 countries, will henceforth operate as the pharmaceutical arm of Nestlé Skin Health S.A.
http://www.nestle.com/media/pressre...s/nestle-acquisition-loreal-galderma-complete

With innovation at the heart of its strategy, Galderma is focused on meeting the needs of patients and physicians in therapeutic, corrective and aesthetic dermatology. Dermatology requires specialised knowledge and unique skills. As a leading player in the industry with 30 years of experience, Galderma’s commitment is to provide patients with a wide range of medical solutions which are effective and well tolerated.
http://www.galderma.com.au/Our-Products